← Association for Accessible Medicines
FDANonrulemakingFDA-2024-D-1245

Data Integrity for In Vivo Bioavailability and Bioequivalence Studies; Draft Guidance for Industry; Availability

RIN
—
Last modified
Jul 3, 2024
Comment window
closed 785d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Jun 4, 2024 and Jun 4, 2024. 0 other organizations filed here. The comment window closed 785d ago.

What Association for Accessible Medicines filed (1)

Jun 4, 2024· Comment from Association for Accessible Medicines (AAM)· FDA-2024-D-1245-0019

Comment letter submitted by Association for Accessible Medicines (AAM) on behalf of our member companies

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (0)

See everyone who commented →